| European Federation of Internal Medicine

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 10 December 2025 - 14:30

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised

Draft guideline on quality of radiopharmaceuticals - Revision 2

Submitted by Anonymous (not verified) on 10 December 2025 - 14:26

Draft guideline on quality of radiopharmaceuticals - Revision 2

Read more about Draft guideline on quality of radiopharmaceuticals - Revision 2

20th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2025, 13:30 (CET) to 13 November 2025, 17:40 (CET)

Submitted by Anonymous (not verified) on 10 December 2025 - 14:25

20th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2025, 13:30 (CET) to 13 November 2025, 17:40 (CET)

Read more about 20th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2025, 13:30 (CET) to 13 November 2025, 17:40 (CET)

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Submitted by Anonymous (not verified) on 10 December 2025 - 14:23

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Read more about Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

Submitted by Anonymous (not verified) on 10 December 2025 - 14:15

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

Read more about Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)

Submitted by Anonymous (not verified) on 10 December 2025 - 14:00

EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)

Read more about EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)

2025 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA), Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 13:00 (CET) to 19 November 2025, 17:45 (C

Submitted by Anonymous (not verified) on 10 December 2025 - 13:56

2025 annual meeting of the members and Coordinating Group of the European network of paediatric research at the EMA (Enpr-EMA), Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 13:00 (CET) to 19 November 2025, 17:45 (CET)